Black Diamond Therapeutics (Series C)

Funding Details
Awarder
Inbox
Date Award
December 05, 2019
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers.
Market
Precision Oncology
Location
Cambridge, MA, USA
Coinvestors
Boxer Capital, BVF Partners, Casdin Capital, Deerfield Management Company, L.P., Invus, Janus Henderson Investors, Logos Capital, New Enterprise Associates, Nextech Invest, RA Capital Management, Versant Ventures, Wellington Management Company

Links
Back to Home Back to Biotechnology Deals View Funding Announcement